Maintenance clinical trials in bipolar disorders: Design implications of the divalproex-lithium-placebo study

Psychopharmacology Bulletin

Volumn 33, Issue 4, 1997, Pages 693-699

  Bowden, Charles L ^a   Swann, Alan C ^b   Calabrese, Joseph R ^c   McElroy, Susan L ^d   Morris, David ^e   Petty, Frederick ^f   Hirschfeld, Robert M A ^g   Gyulai, Laszlo ^h  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UT Mental Science Institute   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e ABBOTT LABORATORIES   (United States)

^f VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^g UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bipolar disorder; Divalproex; Lithium; Valproate

Indexed keywords

LITHIUM; PLACEBO; VALPROATE SEMISODIUM;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; PATIENT SELECTION; PLACEBOS; VALPROIC ACID;

EID: 0031405765     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Benjamin, LS. Statistical treatment of the Law of Initial Values (LIV) in autonomie research: A review and recommendation. Psychosom. Med. 25:556-566, 1963.
2. Bowden, CL; Brugger, AM; Swann, AC; Calabrese, JR; Janicak, PG; Petty, F; Dilsaver, SC; Davis, JM; Rush, AJ; Small, JG; et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 271:918-924, 1994.
3. Bowden, CL; Calabrese, JR; Wallin, BA; Swann, AC; McElroy, SL; Risch, SC; and Hirschfeld, RMA. Who enters therapeutic trials? Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol. Bull. 31:103-109, 1995.
4. Bowden, CL; McElroy, SL; Calabrese, JR; Hirschfeld, RMA; Gyulai, L; Keck, PE, Jr; Wozniak, P; and Rhodes, LR. "Efficacy of Divalproex vs. Lithium and Placebo in the Prophylactic Treatment of Bipolar Disorder." Unpublished manuscript, 1997.
5. Coppen, A; Noguera, R; Bailey, J; Burns, BH; Swani, MS; Hare, EH; Gardner, R; and Maggs, R. Prophylactic lithium in affective disorders. Lancet 2:275-279, 1971.
6. Dion, G; Tohen, M; Anthony, W; and Waternaux, C. Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp. Comm. Psychiatry 39:652-656, 1989.
7. Endicott, J; Spitzer, RL; Fleiss, JD; and Cohen, J. The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33:766-771, 1976.
8. Faedda, GL; Tondo, L; Baldessarini, RJ; Suppes, T; and Tohen, M. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch. Gen. Psychiatry 50:448-456, 1991.
9. Fieve, RR; Kumbaraci, T; and Dunner, DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am. J. Psychiatry 133:925-929, 1976.
10. Fisher, S; Lipman, RS; Uhlenhuth, EH; Rickels, K; and Park, LC. Drug effects and initial severity of symptomatology. Psychopharmacologia 7:57-60, 1965.
11. Gelenberg, AJ; Kane, JM; Keller, MB; Lavori, P; Rosenbaum, JF; Cole, K; and Lavelle, J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med. 321:1489-1493, 1989.
12. Goldberg, JF; Harrow, M; and Grossman, LS. Course and outcome in bipolar affective disorder. Am. J. Psychiatry 152:379-384, 1995.
13. Gyulai, L; Bowden, CL; Calabrese, JR; Keck, PE, Jr. "Effects of Divalproex, Lithium and Placebo on Depressive Symptomatology in Maintenance Treatment of Bipolar Disorder." Unpublished manuscript, 1997.
14. Hirschfeld, RMA; Keller, MB; Panico, S; Arons, BS; Barlow, D; Davidoff, F; Endicott, J; Froom, J; Goldstein, M; Gorman, JM; et al. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. JAMA 277:333-340, 1997.
15. Jamison, KR, and Akiskal, HS. Medication compliance in patients with bipolar disorder. Psychiatr. Clin. North Am. 6(1):175-192, 1983.
16. Jamison, KR; Gerner, RH; and Goodwin, FK. Patient and physician attitudes toward lithium: Relationship to compliance. Arch. Gen. Psychiatry 36:866-869, 1979.
17. Lish, JD; Dime-Meenan, S; Whybrow, PC; Price, RA; and Hirschfeld, RMA. The National Depressive and Manic-Depressive Association (NDMDA) survey of bipolar members. J. Affect. Disord. 31:281-294, 1994.
18. Maj, M; Priozzi, R; and Kemali, D. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders. Psychopharmacology 98:535-538, 1989.
19. Peselow, ED; Fieve, RR; Difiglia, C; and Sanfilipo, MP. Lithium prophylaxis of bipolar illness: The value of combination treatment. Br. J. Psychiatry 164:208-214, 1994.
20. Pope, HG, Jr; McElroy, SL; Keck, PE, Jr; and Hudson, JI. Valproate in the treatment of acute mania: A placebo-controlled study. Arch. Gen. Psychiatry 48:62-68, 1991.
21. Sachs, GS; Lafer, B; Truman, CJ; Noeth, M; Thibault, AB. Lithium monotherapy: Miracle, myth and misunderstanding. Psychiatr. Ann. 24:299-305, 1994.
22. Sheehan, DV. The Anxiety Disease. New York: Bantam Books, 1983. p. 139.
23. Spitzer, RL, and Endicott, J. Schedule for Affective Disorders and Schizophrenia-Change Version (SADS-C). 3d ed. New York: Biometrics Research, 1978.
24. Spitzer, RL; Williams, JBW; Gibbon, M; and First, MB. Instruction Manual for the Structured Clinical Interview for DSM-III-R (SCID). New York: New York State Psychiatric Institute, Biometrics Research, 1988.
25. Suppes, T; Baldessarini, RJ; Faedda, GL; and Tohen, M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch. Gen. Psychiatry 48:1082-1088, 1991.
26. Swann, AC; Bowden, CL; Morris, D; Calabrese, RJ; Petty, F; Small, J; Dilsaver, SC; and Davis, JM. Depression during mania: Treatment response to lithium or divalproex. Arch. Gen. Psychiatry 54:37-42, 1997.
27. Uhlenhuth, EH; Matuzas, W; Warner, TD; and Thompson, PM. Methodological issues in psychopharmacological research. Growing placebo response rate: The problem in recent therapeutic trials? Psychopharmacol. Bull. 33:31-39, 1997.
28. Whitehead, J. The Design and Analysis of Sequential Clinical Trials. London: Ellis Horwood Limited, 1992. pp. 74-176.